Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes

被引:24
作者
Maeda, K
Ishihara, K
Miyake, K
Kaji, Y
Kawamitsu, H
Fujii, M
Sugimura, K
Ohara, T [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Div Diabet & Digest & Kidney Dis, Dept Clin Mol Med, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2005年 / 54卷 / 06期
关键词
D O I
10.1016/j.metabol.2005.01.020
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Adiponectin is an adipose tissue-specific protein and plays an important role in insulin sensitivity. On the other hand, intramyocellular lipid content and hepatic lipid content (HLC) are related to insulin resistance in humans. In the present study, the possible relations between the serum concentration of adiponectin and intracellular triglyceride content in skeletal muscle and in the liver were investigated in individuals with type 2 diabetes mellitus. Fifty Japanese sedentary subjects (34 men, 16 women) with type 2 diabetes who had neither been treated with insulin nor with thiazolidinediones were enrolled in the study. Insulin sensitivity in vivo was evaluated by measurement of the glucose infusion rate during a hyperinsulinemic-euglycemic clamp and of the homeostasis model of assessment-insulin resistance index. The intracellular triglyceride content in skeletal muscle and the liver was determined by nuclear magnetic resonance. The serum adiponectin concentration was inversely correlated with both HLC (r = -0.39, P < .01) and the homeostasis model of assessment-insulin resistance index (r = -0.32, P < .05), but it was not significantly related to either intramyocellular lipid content or glucose infusion rate during the hyperinsulinemic-euglycemic clamp in individuals with type 2 diabetes. These results suggest that adiponectin might play an important role in the regulation of HLC and basal insulin sensitivity in individuals with type 2 diabetes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:775 / 780
页数:6
相关论文
共 50 条
[1]
Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle [J].
Anderwald, C ;
Bernroider, E ;
Krssák, M ;
Stingl, H ;
Brehm, A ;
Bischof, MG ;
Nowotny, P ;
Roden, M ;
Waldhäusl, W .
DIABETES, 2002, 51 (10) :3025-3032
[2]
Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function [J].
Bacha, F ;
Saad, R ;
Gungor, N ;
Arslanian, SA .
DIABETES CARE, 2004, 27 (02) :547-552
[3]
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Piper, P ;
Hardies, LJ ;
Glass, L ;
Cersosimo, E ;
Pratipanawatr, T ;
Miyazaki, Y ;
Defronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :200-206
[4]
BANERJI MA, 1995, INT J OBESITY, V19, P839
[5]
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[6]
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex [J].
Cnop, M ;
Havel, PJ ;
Utzschneider, KM ;
Carr, DB ;
Sinha, MK ;
Boyko, EJ ;
Retzlaff, BM ;
Knopp, RH ;
Brunzell, JD ;
Kahn, SE .
DIABETOLOGIA, 2003, 46 (04) :459-469
[7]
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 [J].
Combs, TP ;
Berg, AH ;
Obici, S ;
Scherer, PE ;
Rossetti, L .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (12) :1875-1881
[8]
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[9]
Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men [J].
Forouhi, NG ;
Jenkinson, G ;
Thomas, EL ;
Mullick, S ;
Mierisova, S ;
Bhonsle, U ;
McKeigue, PM ;
Bell, JD .
DIABETOLOGIA, 1999, 42 (08) :932-935
[10]
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension [J].
Furuhashi, M ;
Ura, N ;
Higashiura, K ;
Murakami, H ;
Tanaka, M ;
Moniwa, N ;
Yoshida, D ;
Shimamoto, K .
HYPERTENSION, 2003, 42 (01) :76-81